Orencia Dexign Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 14 years ago on Monday, September 21, 2009, according to the United State Patent & Trademark Office
Word Mark Orencia Dexign
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 77218655
Status Date Monday, September 21, 2009
Filing Date Monday, September 21, 2009
Attorney Nadine P. Flynn

Correspondent

NADINE P. FLYNN
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
TRADEMARK DEPARTMENT
NEW YORK, NY 10154

Case File Statements

Goods & Services Syringe Pre-Filled with Pharmaceutical Preparations for Treating Auto-Immune Diseases for Human Use
Pseudo Mark Orencia Design

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, July 3, 2007
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.